Otto Alemán Miranda

General Clinical and Surgical Hospital Orlando Pantoja Tamayo, Cuba

*Corresponding Author: Otto Alemán Miranda, General Clinical and Surgical Hospital Orlando Pantoja Tamayo, Cuba.

Received: July 05, 2023; Published: July 28, 2023

Abstract

Diseases caused by fungi have increased in frequency and clinical importance, due to the increased use of potent immunosuppressive drugs in transplants, in anticancer therapy, and by the appearance of viral infections that cause immunodeficiency. The facial skin and the oral mucosa are regions where fungal infections can be found on many occasions. They can be classified in various ways, depending on their evolutionary behavior and form of presentation. Each species tends to produce its own clinical features, although often several of them cause almost identical conditions, other times they are so pathognomonic that it is easy to identify the species, just by examining the affect. Therefore, an exhaustive bibliographical review was carried out on the main orofacial manifestations and risks produced by fungi.

Keywords:Fungal Infections; Immunodeficiency; Pathognomonic

References

1. Díaz González H., et al. “Therapeutic update of skin mycoses”. Gaceta Médica Espirituana 9.3 (2017).
2. Rodríguez Ortega., et al. “Candidiasis of the oral mucosa: Literature review”. Cuban Journal of Stomatology 39.2 (2002). 187-233.
3. Ceccotti E. “Micosis bucales. En: Ceccotti E. Stomatological clinic AIDS, cancer and other conditions”. Buenos Aires: Pan American (1993): 162-16
4. Rebolledo Cobos., et al. “Oral candidiasis in cancer patients undergoing chemotherapy”. Cuban Journal of Stomatology 57.1 (2020): e1965
5. Mothibe JV and Patel M. “Pathogenic characteristics of Candida albicans isolated from oral cavities of denture wearers and cancer patients wearing oral prostheses”. Microbial Pathogenesis 110 (2017): 128-134.
6. Otálora Valderrama S., et al. “Systemic mycoses in non-immunocompromised patients”. Medicine 57 (2018): 3357-3368.
7. García Gómez., et al. “Current situation of systemic candidiasis in hospitalized patients”. Center Medical Record 2 (2020): 182-192.
8. Fernández Andreu., et al. “An update on histoplasmosis”. Cuban Journal of Tropical Medicine 3 (2011): 189-205.
9. Kauffman CA. “Histoplasmosis: a clinical and laboratory update”. Clinical Microbiology Reviews 20 (2007): 115-32.
10. Wheat LJ., et al. “Disseminated histoplasmosis in the acquired immunodeficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature”. Medicine (Baltimore) 69 (1990): 361-374.
11. Wheat LJ., et al. “Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America”. Clinical Infectious Diseases 45 (2007): 807-825.
12. MA Assi., et al. “Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients”. Medicine 86 (2007): 162-169.
13. JW Baddley., et al. “Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy”. Diagnostic Microbiology and Infectious Disease 62 (2008): 151-156.
14. Acha PN and Szyfres B. “Pan American Health Organization [PAHO])”. Zoonoses and communicable diseases common to man and animals. Volume 1. Bacterioses and mycoses. 3^rd Washington DC: PAHO. Scientific and Technical Publication No. 580. Coccidioidomycosis (2003): 320-325.
15. Ampel NM. “Coccidioidomycosis in persons infected with HIV- 1”. Annals of the New York Academy of Sciences 1111 (2007): 336-342.
16. Baptista-Rosas RC., et al. “Ecological niche modeling of Coccidioides spp. in western North American deserts”. Annals of the New York Academy of Sciences 1111 (2007): 35-46.
17. Mata-Essayag S. “Capítulo 29. Microbiología Médica”. Cromotip C.A. Deep Mycoses (2010): 625-44.
18. Delgado W., et al. “Gingival cryptococcosis in a patient with AIDS”. Revista Estomatológica Herediana 1-2 (2004): 78-81.
19. Akram SM and Koirala J. “Cryptococcus (Cryptococcosis), Cutaneous Pathophysiology Treatment/Management”. NCBI (2017): 11-13.
20. Perdomo YC and Takita LC. “Disseminated cryptococcosis with cutaneous involvement in an inmunocompetent patient”. Anais Brasileiros de Dermatologia 6 (2016): 832-834.

21.   Contemporary oral and maxillofacial pathology. J. Philip Sapp. Ed. Elservier. 2° edición (2004).

22.   Araya Rojas Walter., et al. “Aspergillosis of the maxillary sinus secondary to the placement of dental implants. Clinical case report”. Odovtos - International Journal of Dental Sciences 18.1 (2016): 35-43.

23. Arias León., et al. “Zigomicosis”. Infectio2 (2010): s181-s192.

24.   Atlas of Oral diseases, George Laskavis. Ed. Masson. Barcelona, España (2005).

25. Ameen M., et al. “The emergence of mucormycosis as an important opportunistic fungal infection: Five cases presenting to a tertiary referral center for mycology”. International Journal of Dermatology 46 (2007): 380-384. 

Citation

Citation: Otto Alemán Miranda. “Risks and Complications in Fungal Infections". Acta Scientific Dental Sciences 7.8 (2023): 61-67.

Copyright

Copyright: © 2023 Otto Alemán Miranda. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.